Antimicrobial peptide 99mTc-Ubiquicidin 29-41 as human infection-imaging agent: Clinical trial

Journal of Nuclear Medicine

Volumn 46, Issue 4, 2005, Pages 567-573

  Akhtar, Muhammad Saeed ^a   Qaisar, Aitzaz ^a   Irfanullah, Javaid ^a   Iqbal, Javaid ^a   Khan, Bashar ^b,c   Jehangir, Mustansar ^b,c   Nadeem, Muhammad Afzal ^a   Khan, Muhammad Aleem ^a   Afzal, Muhammad Shahzad ^a   Ul Haq, Ikram ^c   Imran, Muhammad Babar ^a  

^a PUNJAB MEDICAL COLLEGE   (Pakistan)

^b PAKISTAN INSTITUTE OF NUCLEAR SCIENCE AND TECHNOLOGY   (Pakistan)

^c Allied Hospital Pakistan   (Pakistan)

Author keywords

Antimicrobial peptide; Infection imaging; Target to nontarget; Ubiquicidin

Indexed keywords

TECHNETIUM 99M; UBIQUICIDIN 29 41 TC 99M; UNCLASSIFIED DRUG; ANTIMICROBIAL CATIONIC PEPTIDE; DIAGNOSTIC AGENT; PEPTIDE FRAGMENT; RADIOPHARMACEUTICAL AGENT; TECHNETIUM 99M UBIQUICIDIN(29 41); TECHNETIUM 99M UBIQUICIDIN(29-41); TECHNETIUM COMPLEX;

ADOLESCENT; ADULT; AGED; ARTICLE; BONE INFECTION; BONE SCINTISCANNING; CHILD; CLINICAL ARTICLE; CLINICAL TRIAL; DRUG SAFETY; FEMALE; HUMAN; MALE; PAPER CHROMATOGRAPHY; PRIORITY JOURNAL; PROSTHESIS INFECTION; RADIOACTIVITY; SCORING SYSTEM; SOFT TISSUE INFECTION; ANTIBODY SPECIFICITY; BACTERIAL INFECTION; METABOLIC CLEARANCE RATE; METABOLISM; MIDDLE AGED; OSTEITIS; PILOT STUDY; PRESCHOOL CHILD; REPRODUCIBILITY; SCINTISCANNING; SENSITIVITY AND SPECIFICITY; TISSUE DISTRIBUTION; VALIDATION STUDY;

ADOLESCENT; ADULT; AGED; ANTIMICROBIAL CATIONIC PEPTIDES; BACTERIAL INFECTIONS; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; MALE; METABOLIC CLEARANCE RATE; MIDDLE AGED; ORGAN SPECIFICITY; ORGANOTECHNETIUM COMPOUNDS; OSTEITIS; PEPTIDE FRAGMENTS; PILOT PROJECTS; RADIOPHARMACEUTICALS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; SOFT TISSUE INFECTIONS; TISSUE DISTRIBUTION;

EID: 19644363678     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Palestre CJ. The current role of gallium imaging in infection. Semin Nucl Med. 1994;24:128-141.
2. 99mTc-HMPAO leucocytes for imaging infection. Semin Nucl Med. 1994;24:110-127.
3. Fischman AJ, Rauh D, Solomon H, et al. In vivo bioactivity and biodistribution of chemotactic peptide analogs in nonhuman primates. J Nucl Med. 1993;34: 2130-2134.
4. 99mTc-ciprofloxacin (Infecton). J Clin Pathol. 2002;11:817-823.
5. Limoncu MH, Ermertcan S, Cetin CB, Cosar G, Dine G. Emergence of phenotypic resistance to ciprofloxacin and levofloxacin in methicillin resistant and methicillin-sensitive staphylococcus aureus strains. Int J Antimicrob Agents. 2003;5:420-424.
6. Yapar Z, Kibar M, Yapar AF, Togrul E, Kayaselcuk U, Sarpel Y. The efficacy of technetium-99m-ciprofloxacin (Infecton) imaging in suspected orthopaedic infection: a comparison with sequential bone/gallium imaging. Eur J Nucl Med. 2001;28:822-830.
7. Ganz ME, Lehrer RI. Defensins and other endogenous peptide antibiotics of the vertebrates. J Leukoc Biol. 1995;58:128-136.
8. Epand RM, Vogel HJ. Diversity of antimicrobial peptides and their mechanisms of action. Biochim Biophys Acta. 1999;1462:11-28.
9. Lupetti A, Nibbering PH, Welling MM, Pauwels EKJ. Radiopharmaceuticals: new antimicrobial agents. Trends Biotech. 2003;21:70-73.
10. Hiemstra PS, Van den Barselaar MT, Roest M, et al. Ubiquicidin, a novel murine microbicidal protein in the cytosolic fraction of the activated macrophages. J Leukocyte Biol. 1999;66:423-428.
11. Welling MM, Paulusma-Annema A, Baiter HS, Pauwels EKJ, Nibbering PH. Technetium-99m labeled antimicrobial peptides discriminate between bacterial infections and sterile inflammations. Eur J Nucl Med. 2000;27:292-301.
12. 99mTc-labeled antimicrobial peptides for detection of bacterial and Candida albicans infections. J Nucl Med. 2001;42: 788-794.
13. 99mTc-UBI specificity for bacteria. Nucl Med Biol. 2003;30: 597-603.
14. 99mTc-Labeled antimicrobial peptide ubiquicidin (29-41) accumulates less in Escherichia coli infection than in Staphylococcus aureus infection. J Nucl Med. 2004;45:849-856.
15. 99mTc-UBI 29-41 in humans. Nucl Med Biol. 2004;31:373-379.
16. Thrall JH, Ziessman HA. Nuclear Medicine: The Requisites. 2nd ed. St. Louis, MO: Mosby, Inc.; 2001:60.
17. 99mTc-Labeled UBI 29-41 peptide for monitoring the efficacy of antimicrobial agents in mice infected with Staphylococcus aureus. J Nucl Med. 2004;45:321-326.